Population Pharmacokinetics of Perphenazine in Schizophrenia Patients From CATIE: Impact of Race and Smoking

Journal of Clinical Pharmacology - United States
doi 10.1177/0091270009343694
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Cigarette Smoking in Patients With Schizophrenia

British Journal of Psychiatry
MedicinePsychiatryMental Health
2000English

Population Pharmacokinetics of Anidulafungin in Critically Ill Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Investigation of Cigarette Smoking Among Male Schizophrenia Patients

PLoS ONE
Multidisciplinary
2013English

Population Pharmacokinetics of Pyrazinamide in Patients With Tuberculosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients

Clinical Drug Investigation
MedicinePharmacology
2013English

Population Pharmacokinetics and Dosing Optimization of Linezolid in Pediatric Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

A Candidate Gene Study of Tardive Dyskinesia in the CATIE Schizophrenia Trial

American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics
PsychiatryMolecular NeuroscienceMental HealthGeneticsCellular
2009English

Population Pharmacokinetics of Intramuscular Droperidol in Acutely Agitated Patients

British Journal of Clinical Pharmacology
Pharmacology
2016English

Could Smoking Increase the Risk for Metabolic Syndrome Among Patients With Schizophrenia in a Croatian Population?

Medicina Fluminensis
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy